Healthcare group Uniphar reports 8% increase in profits

Dublin and London-listed group focuses on delivery of medical information

Uniphar, which was listed in Dublin and London in a €139m flotation in 2020, focuses on the delivery of medical information to patients, healthcare practitioners and others

Uniphar, which was listed in Dublin and London in a €139m flotation in 2020, focuses on the delivery of medical information to patients, healthcare practitioners and others

 

Healthcare services group Uniphar has reported increased earnings and profits for last year on the back of what it described as “an outperformance in the supply chain and retail division”.

The company said profits grew by over 8 per cent. “This represents a strong performance during the period, demonstrating the diversity of the group’s service offering and the benefit of the group’s focus and investment in technology platforms,” it said.

“Organic gross profit growth was driven by the commercial and clinical and product access divisions performing strongly, and an outperformance in the supply chain and retail division,” it added.

Uniphar, which was listed in Dublin and London in a €139 million flotation in 2020, focuses on the delivery of medical information to patients, healthcare practitioners and others.

It acquired Ireland’s largest family-owned pharmacy chain Hickey’s in 2020 in a deal said to be worth up to €60 million.

“Mergers and acquisitions will continue to play an important part in Uniphar’s growth strategy, and the group continues to have a disciplined approach in managing an active pipeline of acquisition opportunities to further enhance the group’s growth potential,” it said.